Skip to main content

Market Overview

Revance Therapeutics (NASDAQ: RVNC)

31.84 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:




Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-1.34
3.835M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-1.15
58K
-1.09
10.98M
-1.08
13.299M
0.92%
21.12%
Q4 2020
After-Hours
EPS:
REV:
-0.99
89K
-1.24
8.78M
-1.24
11.133M
0%
26.8%
Q3 2020
After-Hours
EPS:
REV:
-0.96
46K
-1.03
1.78M
-1.34
3.835M
-30.1%
115.45%
Q2 2020
After-Hours
EPS:
REV:
-0.86
0
-1.01
450K
-1.12
299K
-10.89%
-33.56%
Q1 2020
After-Hours
EPS:
REV:
-0.85
278K
-0.90
170K
-1.15
58K
-27.78%
-65.88%
Q4 2019
After-Hours
EPS:
REV:
-1.12
487K
-0.98
2.29M
-0.99
89K
-1.02%
-96.11%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!